购物车
- 全部删除
- 您的购物车当前为空
Anti-NASH agent 1 (compound 3d),Elafibranor衍生物,高效PPAR-α/δ激动剂,针对非酒精性脂肪性肝炎(NASH)。以3-10 mg/kg剂量,连续4周处理,能显著改善蛋氨酸胆碱缺乏(MCD)诱导的NASH小鼠高脂血症、肝脏脂肪变性及炎症状况,展现出低肝毒性和良好肝脏保护效能。
Anti-NASH agent 1 (compound 3d),Elafibranor衍生物,高效PPAR-α/δ激动剂,针对非酒精性脂肪性肝炎(NASH)。以3-10 mg/kg剂量,连续4周处理,能显著改善蛋氨酸胆碱缺乏(MCD)诱导的NASH小鼠高脂血症、肝脏脂肪变性及炎症状况,展现出低肝毒性和良好肝脏保护效能。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 10,600 | 6-8周 | |
50 mg | ¥ 13,800 | 6-8周 | |
100 mg | ¥ 17,500 | 6-8周 |
产品描述 | Anti-NASH Agent 1 (Compound 3d), derived from Elafibranor, serves as a strong PPAR-α/δ agonist aimed at treating nonalcoholic steatohepatitis (NASH). At dosages of 3-10 mg/kg over four weeks, this compound ameliorates hyperlipidemia, liver fat degeneration, and inflammation in a methionine-choline deficiency (MCD)-induced NASH mouse model, exhibiting minimal hepatotoxicity while providing substantial hepatic protection [1]. |
分子量 | 423.54 |
分子式 | C26H33NO4 |
CAS No. | 2409685-41-0 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容